AGX

SEC source: 0001415889-22-004228 · form4-04222022_010456.xml · nonDerivative · entry 1

Jeffrey John Ronald Jr. · CIK 0001709914 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · John R. Jeffrey, IRA

Disclosed balance after: 7,000

F1 · shares: On April 22, 2022, the Reporting Person purchased 1,000 shares of the Issuer's Common Stock on the open market at a price of $36.97 per share.

SEC source: 0001415889-22-004132 · form4-04192022_040416.xml · derivative · entry 3

Deily Richard H · CIK 0001358787 · VICE PRESIDENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,834

Underlying: Common Stock · 3,500 shares

Expires not disclosed

F5 · derivative.exercise_date: On April 18, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 3,500 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/18/2023.

F5 · derivative.expiration_date: On April 18, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 3,500 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/18/2023.

F6 · balance_after: As of the date of this filing, the remaining number of TBRSUs beneficially owned by the Reporting Person includes (a) 2,334 shares of TBRSUs granted on April 12, 2021; and (b) 3,500 shares of TBRSUs granted on April 18, 2022, all to vest pursuant to the three year vesting schedule reported under footnote 5 above.

SEC source: 0001415889-22-004132 · form4-04192022_040416.xml · derivative · entry 2

Deily Richard H · CIK 0001358787 · VICE PRESIDENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,000

Underlying: Common Stock · 3,500 shares

Expires 2032-04-18

F2 · shares: On April 18, 2022, the Reporting Person received 10-year options to purchase 3,500 shares of the Issuer's common stock with an exercise price of $36.78 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/18/2023.

F3 · balance_after: As of the date of this Filing, the total number of options owned by the Reporting Person includes (a) options to purchase a total of 10,000 shares of common stock at the price of $33.85 per share with the date exercisable of 04/13/2017 and expiration date of 04/13/2026; (b) options to acquire 10,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (c) options to acquire 10,000 shares of common stock at a price of $37.60 per share with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028; (d) options to acquire 10,000 shares of common stock at a price of $50.30 per share with Date Exercisable of 4/12/2020 and Expiration Date of 4/12/2029;

F4 · balance_after: (e) options to acquire 10,000 shares of common stock at a price of $33.81 per share with a Date Exercisable of 4/16/2021 and Expiration Date of 4/16/2030; (f) options to acquire 3,500 shares of common stock at a price of $54.60 per share with a Date Exercisable of 4/16/2022 and Expiration Date of 4/16/2031, and (g) options to acquire 3,500 shares of common stock at a price of $36.78 per share with a Date Exercisable of 4/18/2023 and Expiration Date of 4/18/2032. Options identified in subjects (c), (d), (e), (f) and (g) are subject to the aforementioned three-year ratably vesting schedule.

SEC source: 0001415889-22-004131 · form4-04192022_040407.xml · derivative · entry 4

Watson David Hibbert · CIK 0001482442 · SVP AND CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F7 · derivative.exercise_date: On April 18, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 10,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/18/2023.

F7 · derivative.expiration_date: On April 18, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 10,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/18/2023.

F8 · balance_after: As of the date of this filing, the remaining number of TBRSUs beneficially owned by the Reporting Person includes (a) 6,667 shares of TBRSUs granted on April 12, 2021; and (b) 10,000 shares of TBRSUs granted on April 18, 2022, all to vest pursuant to the three year vesting schedule reported under footnote 7 above.

SEC source: 0001415889-22-004131 · form4-04192022_040407.xml · derivative · entry 3

Watson David Hibbert · CIK 0001482442 · SVP AND CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F5 · derivative.exercise_date: On April 18, 2022, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 10,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2022 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F5 · derivative.expiration_date: On April 18, 2022, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 10,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2022 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F6 · balance_after: As of the date of this filing, the total number of PBRSUs owned by the Reporting Person includes (a) a target number of 10,000 shares of PBRSUs granted on April 16, 2020; (b) a target number of 10,000 shares of PBRSUs granted on April 16, 2021, and (c) a target number of 10,000 shares of PBRSUs granted on April 18, 2022; all to vest in their entirety at the end of a three-year performance period as generally reported under footnote 5 above.

SEC source: 0001415889-22-004131 · form4-04192022_040407.xml · derivative · entry 2

Watson David Hibbert · CIK 0001482442 · SVP AND CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,000

Underlying: Common Stock · 10,000 shares

Expires 2032-04-18

F2 · shares: On April 18, 2022, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $36.78 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/18/2023.

F3 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 30,000 shares of common stock at a price of $41.68 with Date Exercisable of 06/23/2017 and Expiration Date of 06/23/2026; (b) options to acquire 40,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (c) options to acquire 32,000 shares of common stock at a price of $37.60 per share with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028; (d) options to acquire 32,000 shares of common stock at a price of $50.30 with a Date Exercisable of 4/12/2020 and Expiration date of 4/12/2029;

F4 · balance_after: (e) options to acquire 32,000 shares of common stock at a price of $33.81 with a Date Exercisable of 4/16/2021 and Expiration Date of 4/16/2030, (f) options to acquire 10,000 shares of common stock at a price of $54.60 with a Date Exercisable of 4/16/2022 and Expiration Date of 4/16/2031, and (g) options to acquire 10,000 shares of common stock at a price of $36.78 per share with Date Exercisable 4/18/2023 and Expiration Date of 4/18/2032; all subject to the aforementioned three-year ratably vesting schedule.

SEC source: 0001415889-22-004130 · form4-04192022_040402.xml · derivative · entry 4

BOSSELMANN RAINER H · CIK 0001028546 · CHAIRMAN & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,834

Underlying: Common Stock · 12,500 shares

Expires not disclosed

F8 · derivative.exercise_date: On April 18,2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 12,500 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/18/2023.

F8 · derivative.expiration_date: On April 18,2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 12,500 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/18/2023.

F9 · balance_after: As of the date of this filing, the remaining number of TBRSUs beneficially owned by the Reporting Person includes (a) 8,334 shares of TBRSUs granted on April 12, 2021; and (b) 12,500 shares of TBRSUs granted on April 18, 2022, all to vest pursuant to the three year vesting schedule reported under footnote 8 above.

SEC source: 0001415889-22-004130 · form4-04192022_040402.xml · derivative · entry 3

BOSSELMANN RAINER H · CIK 0001028546 · CHAIRMAN & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 12,500 shares

Expires not disclosed

F6 · derivative.exercise_date: On April 18, 2022, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 12,500 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2022 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period

F6 · derivative.expiration_date: On April 18, 2022, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 12,500 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2022 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period

F7 · balance_after: As of the date of this filing, the remaining number of PBRSUs beneficially owned by the Reporting Person includes (a) a target number of 12,500 shares of PBRSUs granted on April 16, 2020; (b) a target number of 12,500 shares of PBRSUs granted on April 16, 2021; and (c) a target number of 12,500 shares of PBRSUs granted on April 18, 2022, all to vest in their entirety at the end of a three-year performance period.

SEC source: 0001415889-22-004130 · form4-04192022_040402.xml · derivative · entry 2

BOSSELMANN RAINER H · CIK 0001028546 · CHAIRMAN & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 320,000

Underlying: Common Stock · 12,500 shares

Expires 2032-04-18

F3 · shares: On April 18, 2022, the Reporting Person received 10-year options to purchase 12,500 shares of the Issuer's common stock with an exercise price of $36.78 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/18/2023.

F4 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 25,000 shares of common stock at a price of $16.37 per share with Date Exercisable of 03/07/2014 and Expiration Date of 03/07/2023; (b) options to acquire 50,000 shares of common stock at a price of $32.68 with Date Exercisable of 04/16/2016 and Expiration Date of 04/16/2025; (c) options to acquire 50,000 shares of common stock at a price of $33.85 per share with Date Exercisable of 04/13/2017 and Expiration Date of 04/13/2026; (d) options to acquire 50,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (e) options to acquire 40,000 shares of common stock at a price of $37.60 per share with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028;

F5 · balance_after: (f) options to acquire 40,000 shares of common stock at a price of $50.30 per share with Date Exercisable of 4/12/2020 and Expiration Date of 4/12/2029; (g) options to acquire 40,000 shares of common stock at a price of $33.81 per share with Date Exercisable 4/16/2021 and Expiration Date of 4/16/2030; (h) options to acquire 12,500 shares of common stock at a price of $54.60 with Date Exercisable of 4/16/2022 and Expiration Date of 4/16/2031 and (i) options to acquire 12,500 shares of common stock at a price of $36.78 per share with Date Exercisable of 4/18/2023 and Expiration Date of 4/18/2032; all of which are subject to the aforementioned three-year ratably vesting schedule

SEC source: 0001415889-22-004183 · form4-04202022_040401.xml · derivative · entry 2

Griffin William F Jr · CIK 0001384123 · Director · GEMMA, NON-EXECUTIVE CHAIRMAN

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires not disclosed

F1 · derivative.exercise_date: On April 18, 2022, the Reporting Person was granted Time-Based Restricted Stock Units ( the "TBRSUs") covering 12,500 shares of the Issuer's Common Stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/18/2023.

F1 · derivative.expiration_date: On April 18, 2022, the Reporting Person was granted Time-Based Restricted Stock Units ( the "TBRSUs") covering 12,500 shares of the Issuer's Common Stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/18/2023.

SEC source: 0001415889-22-004215 · form4-04212022_040401.xml · derivative · entry 5

Collins Charles Edwin IV · CIK 0001791800 · CHIEF EXECUTIVE OFFICER, GEMMA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 5,000 shares

Expires 2032-04-18

F8 · shares: On April 18, 2022, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's common stock with an exercise price of $36.78 per share. The options will vest ratably over three year on each anniversary of the grant date starting from 04/18/2023.

F9 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 5,000 shares of common stock at a price of $46.35 with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (b) options to acquire 25,000 shares of common stock at a price of $43.10 with Date Exercisable of 9/12/2019 and Expiration Date of 9/12/2028; (c) options to acquire 10,000 shares of common stock at a price of $42.31 with Date Exercisable of 9/10/2020 and Expiration Date of 9/10/2029;

F10 · balance_after: (d) options to acquire 10,000 shares of common stock at a price of $33.81 with Date Exercisable on 4/16/2021 and Expiration Date 4/16/2030; and (e) options to acquire 5,000 shares of common stock at a price of $36.78 with Date Exercisable of 4/18/2023 and Expiration Date of 4/18/2032; all of which will vest ratably over three years from their respective grant date.

SEC source: 0001415889-22-004215 · form4-04212022_040401.xml · derivative · entry 4

Collins Charles Edwin IV · CIK 0001791800 · CHIEF EXECUTIVE OFFICER, GEMMA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,334

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F6 · derivative.exercise_date: On April 18, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 10,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/18/2023.

F6 · derivative.expiration_date: On April 18, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 10,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/18/2023.

F7 · balance_after: As of the date of this filing, the total number of TBRSUs owned by the reporting person include (a) 3,334 shares of TBRSUs granted on April 16, 2021; and (b) 10,000 shares of TBRSUs granted on April 18, 2022; all to vest according to the three-year vesting schedule described in footnote 6 above.

SEC source: 0001415889-22-004215 · form4-04212022_040401.xml · derivative · entry 3

Collins Charles Edwin IV · CIK 0001791800 · CHIEF EXECUTIVE OFFICER, GEMMA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 7,500 shares

Expires not disclosed

F4 · derivative.exercise_date: On April 18, 2022, the Reporting Person was granted Renewable Performance-Based Restricted Stock Units (the "RRSUs") in the target number of 7,500 shares, the vesting of which is subject to Gemma Power Systems, LLC and its affiliates obtaining new renewable energy projects with an aggregate contract value exceeding certain identified hurdle amounts for each of the performance periods. The four performance periods cover three consecutive one-year periods each with a target number of 1,500 shares and a cumulative total at the end of the three-year performance period with a target number of 3,000 shares. The awards will be more fully described in the Issuer's 2022 Proxy Statement. Each RRSU represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.expiration_date: On April 18, 2022, the Reporting Person was granted Renewable Performance-Based Restricted Stock Units (the "RRSUs") in the target number of 7,500 shares, the vesting of which is subject to Gemma Power Systems, LLC and its affiliates obtaining new renewable energy projects with an aggregate contract value exceeding certain identified hurdle amounts for each of the performance periods. The four performance periods cover three consecutive one-year periods each with a target number of 1,500 shares and a cumulative total at the end of the three-year performance period with a target number of 3,000 shares. The awards will be more fully described in the Issuer's 2022 Proxy Statement. Each RRSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · balance_after: As of the date of this filing, the total number of RRSUs owned by the reporting person include (a) a target number of 5,000 shares of RRSUs granted on April 16, 2021; and (b) a target number of 7,500 shares of RRSUs granted on April 18, 2022; all to vest according to the three-year performance schedule described in footnote 4 above.

SEC source: 0001415889-22-004215 · form4-04212022_040401.xml · derivative · entry 2

Collins Charles Edwin IV · CIK 0001791800 · CHIEF EXECUTIVE OFFICER, GEMMA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Underlying: Common Stock · 1,000 shares

Expires not disclosed

F2 · derivative.exercise_date: On April 18, 2022, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 1,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2022 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F2 · derivative.expiration_date: On April 18, 2022, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 1,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2022 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F3 · balance_after: As of the date of this filing, the total number of PBRSUs owned by the Reporting Person includes (a) a target number of 1,000 shares of PBRSUs granted on April 16, 2021; and (b) a target number of 1,000 shares of PBRSUs granted on April 18, 2022; all to vest according the three-year performance period described in footnote 2 above.

SEC source: 0001415889-22-004133 · form4-04192022_040421.xml · derivative · entry 2

trebilcock Terrance Colin · CIK 0001791304 · PRESIDENT, GEMMA POWER SYS.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,334

Underlying: Common Stock · 1,705 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: As of the date of this filing, the remaining number of TBRSUs beneficially owned by the Reporting Person includes 3,334 shares of TBRSUs granted on April 12, 2021. The shares vest according to the three year vesting schedule mentioned in footnote 1 above.

F2 · derivative.expiration_date: As of the date of this filing, the remaining number of TBRSUs beneficially owned by the Reporting Person includes 3,334 shares of TBRSUs granted on April 12, 2021. The shares vest according to the three year vesting schedule mentioned in footnote 1 above.

F2 · derivative.underlying_shares: As of the date of this filing, the remaining number of TBRSUs beneficially owned by the Reporting Person includes 3,334 shares of TBRSUs granted on April 12, 2021. The shares vest according to the three year vesting schedule mentioned in footnote 1 above.

SEC source: 0001415889-22-004133 · form4-04192022_040421.xml · nonDerivative · entry 1

trebilcock Terrance Colin · CIK 0001791304 · PRESIDENT, GEMMA POWER SYS.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,705

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 16, 2022, the Reporting Person had Time-Based Restricted Stock Units (the "TBRSUs") vest in the amount of 1,705 shares of the Issuer's Common Stock. This issuance is pursuant to the three year vesting schedule of the 5,000 TBRSU award that was granted on April 16, 2021 and is adjusted for cash dividends.

SEC source: 0001415889-22-004132 · form4-04192022_040416.xml · nonDerivative · entry 1

Deily Richard H · CIK 0001358787 · VICE PRESIDENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,193

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 16, 2022, the Reporting Person had Time-Based Restricted Stock Units (the "TRSUs") vest in the amount of 1,193 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 3,500 TRSU award that was granted on April 16, 2022 and is adjusted for cash dividends.

SEC source: 0001415889-22-004131 · form4-04192022_040407.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · SVP AND CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,895

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 16, 2022, the Reporting Person had Time-Based Restricted Stock Units (the "TBRSUs") vest in the amount of 3,411 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 10,000 TBRSU award that was granted on April 16, 2021 and is adjusted for cash dividends.

SEC source: 0001415889-22-004130 · form4-04192022_040402.xml · nonDerivative · entry 1

BOSSELMANN RAINER H · CIK 0001028546 · CHAIRMAN & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 365,390

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 16, 2022, the Reporting Person had Time-Based Restricted Stock Units (the "TRSUs") vest in the amount of 4,264 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 12,500 TRSU award that was granted on April 16, 2021 and is adjusted for cash dividends.

F2 · balance_after: 2,241 shares are held by Rainer and Beverley Bosselmann, as joint tenants, and the remaining shares are held directly by Rainer Bosselmann.

SEC source: 0001415889-22-004215 · form4-04212022_040401.xml · nonDerivative · entry 1

Collins Charles Edwin IV · CIK 0001791800 · CHIEF EXECUTIVE OFFICER, GEMMA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,705

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 16, 2022, the Reporting Person had Time-Based Restricted Stock Units (the "TBRSUs") vest in the amount of 1,705 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 5,000 TBRSU award that was granted on April 16, 2021 and is adjusted for cash dividends.

SEC source: 0001415889-22-004064 · form4-04142022_040406.xml · derivative · entry 2

BOSSELMANN RAINER H · CIK 0001028546 · CHAIRMAN & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: As of the date of this filing, the remaining number of PBRSUs beneficially owned by the Reporting Person includes (a) a target number of 12,500 shares of PBRSUs granted on April 16, 2020 and (b) a target number of 12,500 shares of PBRSUs granted on April 16, 2021; all to vest in their entirety at the end of a three-year performance period.

F3 · derivative.expiration_date: As of the date of this filing, the remaining number of PBRSUs beneficially owned by the Reporting Person includes (a) a target number of 12,500 shares of PBRSUs granted on April 16, 2020 and (b) a target number of 12,500 shares of PBRSUs granted on April 16, 2021; all to vest in their entirety at the end of a three-year performance period.

F3 · balance_after: As of the date of this filing, the remaining number of PBRSUs beneficially owned by the Reporting Person includes (a) a target number of 12,500 shares of PBRSUs granted on April 16, 2020 and (b) a target number of 12,500 shares of PBRSUs granted on April 16, 2021; all to vest in their entirety at the end of a three-year performance period.

SEC source: 0001415889-22-004064 · form4-04142022_040406.xml · nonDerivative · entry 1

BOSSELMANN RAINER H · CIK 0001028546 · CHAIRMAN & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 361,126

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 12, 2022, the Reporting Person had Performance-Based Restricted Stock Units (the "PBRSUs") vest in the amount of 11,231 shares of Common Stock. These PBRSUs, which were granted April 12, 2019 with a target number of 10,000 shares (the "Target"), had vesting subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies disclosed in the Issuer's 2019 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The potential payout ratio of the Target, ranged from 0% to 200%, depending on the degree of achievement of the percentile of the TSR. The performance achievement over the measurement period resulted in the vesting of 100% of the Target plus an adjustment for cash dividends.

F2 · balance_after: 2,241 shares are held by Rainer and Beverley Bosselmann, as joint tenants, and the remaining shares are held directly by Rainer Bosselmann.

SEC source: 0001415889-22-004063 · form4-04142022_040401.xml · derivative · entry 2

Watson David Hibbert · CIK 0001482442 · SVP AND CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 8,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: As of the date of this filing, the remaining number of PBRSUs beneficially owned by the Reporting Person includes (a) a target number of 10,000 shares of PBRSUs granted on April 16, 2020 and (b) a target number of 10,000 shares of PBRSUs granted on April 16, 2021; all to vest in their entirety at the end of a three-year performance period.

F3 · derivative.expiration_date: As of the date of this filing, the remaining number of PBRSUs beneficially owned by the Reporting Person includes (a) a target number of 10,000 shares of PBRSUs granted on April 16, 2020 and (b) a target number of 10,000 shares of PBRSUs granted on April 16, 2021; all to vest in their entirety at the end of a three-year performance period.

F3 · balance_after: As of the date of this filing, the remaining number of PBRSUs beneficially owned by the Reporting Person includes (a) a target number of 10,000 shares of PBRSUs granted on April 16, 2020 and (b) a target number of 10,000 shares of PBRSUs granted on April 16, 2021; all to vest in their entirety at the end of a three-year performance period.

SEC source: 0001415889-22-004063 · form4-04142022_040401.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · SVP AND CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,484

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 12, 2022, the Reporting Person had Performance-Based Restricted Stock Units (the "PBRSUs") vest in the amount of 8,984 shares of Common Stock. These PBRSUs, which were granted April 12, 2019 with a target number of 8,000 shares (the "Target"), had vesting subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies disclosed in the Issuer's 2019 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The potential payout ratio of the Target, ranged from 0% to 200%, depending on the degree of achievement of the percentile of the TSR. The performance achievement over the measurement period resulted in the vesting of 100% of the Target plus an adjustment for cash dividends.

F2 · balance_after: Assuming the trading window opens shortly after the year end financials are released or later this year, the Reporting Person intends to sell a portion of these shares primarily for the purposes of paying taxes related to the vesting of these shares.

SEC source: 0001415889-22-000728 · form4-01242022_040103.xml · nonDerivative · entry 1

Griffin William F Jr · CIK 0001384123 · Director · GEMMA, NON-EXECUTIVE CHAIRMAN

10b5-1 filing: Not disclosed

Ownership: Indirect · By William F Griffin Jr Revocable Trust U/A DTD FBO 12/09/04

Disclosed balance after: 170,000

F1 · shares: On December 29, 2021, the Reporting Person made a donation of 26,150 shares of the Issuer's Common Stock to the Peach Pit Foundation, Sharon K Griffin Trustee. The transfer of these restricted shares was completed on January 21, 2022.

SEC source: 0001415889-21-006029 · form4-12162021_041225.xml · derivative · entry 5

Leimkuhler William F. · CIK 0001361943 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,750

Underlying: Common Stock · 1,750 shares

Expires 2024-12-14

F4 · shares: On December 14, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/14/2024.

SEC source: 0001415889-21-006029 · form4-12162021_041225.xml · derivative · entry 4

Leimkuhler William F. · CIK 0001361943 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common Stock · 5,000 shares

Expires 2031-12-14

F1 · shares: On December 14, 2021, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $37.13 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/14/2022

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of Common Stock at a price of $26.88 per share with initial Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) 10,000 shares of Common Stock at a price of $31.82 per share with initial Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) 10,000 shares of Common Stock at a price of $30.44 per share with initial Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (e) 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (f) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028;

F3 · balance_after: (g) 10,000 shares of common stock at a price of $40.15 with initial Date Exercisable of 12/23/2020 and an Expiration Date of 12/23/2029; (h) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; and (i) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award.

SEC source: 0001415889-21-006028 · form4-12162021_041221.xml · derivative · entry 5

Getsinger Peter W · CIK 0001627519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,750

Underlying: Common Stock · 1,750 shares

Expires 2024-12-14

F4 · shares: On December 14, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/14/2024.

SEC source: 0001415889-21-006028 · form4-12162021_041221.xml · derivative · entry 4

Getsinger Peter W · CIK 0001627519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,000

Underlying: Common Stock · 5,000 shares

Expires 2031-12-14

F1 · shares: On December 14, 2021, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $37.13 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/14/2022.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 7,000 shares of common stock at a price of $30.44 per share with initial Date Exercisable of 01/07/2017 and Expiration Date of 01/07/2026; (b) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 01/05/2018 and Expiration Date of 01/05/2027; (c) 10,000 shares of common stock at a price of $46 35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (d) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable on 12/12/2019 and Expiration Date of 12/12/2028; (e) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable on 12/23/2020 and Expiration Date of 12/23/2029; and (f) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; and

F3 · balance_after: (g) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award.

SEC source: 0001415889-21-006027 · form4-12162021_041216.xml · derivative · entry 3

Koilpillai Mano S · CIK 0001790160 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,750

Underlying: Common Stock · 1,750 shares

Expires 2024-12-14

F3 · shares: On December 14, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/14/2024.

SEC source: 0001415889-21-006027 · form4-12162021_041216.xml · derivative · entry 2

Koilpillai Mano S · CIK 0001790160 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,667

Underlying: Common Stock · 5,000 shares

Expires 2031-12-14

F1 · shares: On December 14, 2021, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $37.13 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/14/2022.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $42.31 per share with initial Date Exercisable of 9/10/2020 and Expiration Date of 9/10/2029; (b) 6,667 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; (c) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; and (d) 5,000 shares of common stock at a price of $37.13 per share with an initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031; all of which vest ratably over three years on the anniversary of each grant date.

SEC source: 0001415889-21-006026 · form4-12162021_041211.xml · derivative · entry 3

Jeffrey John Ronald Jr. · CIK 0001709914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,750

Underlying: Common Stock · 1,750 shares

Expires 2024-12-14

F4 · shares: On December 14, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/14/2024.

SEC source: 0001415889-21-006026 · form4-12162021_041211.xml · derivative · entry 2

Jeffrey John Ronald Jr. · CIK 0001709914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 5,000 shares

Expires 2031-12-14

F1 · shares: On December 14, 2021, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $37.13 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/14/2022.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $60.05 per share with initial Date Exercisable of 06/22/2018 and Expiration Date of 06/22/2027; (b) 10,000 shares of common stock at a price of $46 35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (c) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028; (d) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029;

F3 · balance_after: (e) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable 12/14/2021 and Expiration Date of 12/14/2030; and (f) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award.

SEC source: 0001415889-21-006025 · form4-12162021_041206.xml · derivative · entry 3

QUINN JAMES W · CIK 0001094454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,750

Underlying: Common Stock · 1,750 shares

Expires 2024-12-14

F5 · shares: On December 14, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of their grant date on 12/14/2024.

SEC source: 0001415889-21-006025 · form4-12162021_041206.xml · derivative · entry 2

QUINN JAMES W · CIK 0001094454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common Stock · 5,000 shares

Expires 2031-12-14

F1 · shares: On December 14, 2021, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $37.13 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/14/2022.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $26.88 with initial Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) 10,000 shares of common stock at a price of $31.82 per share with initial Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) 10,000 shares of common stock at a price of $30.44 per share with initial Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027;

F3 · balance_after: (e) 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (f) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028; (g) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; (h) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; and

F4 · balance_after: (i) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031. All stock options are subject to the aforementioned three year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award.

SEC source: 0001415889-21-006024 · form4-12162021_041201.xml · derivative · entry 3

Flanders Cynthia · CIK 0001463638 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,750

Underlying: Common Stock · 1,750 shares

Expires 2024-12-14

F5 · shares: On December 14, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/14/2024.

SEC source: 0001415889-21-006024 · form4-12162021_041201.xml · derivative · entry 2

Flanders Cynthia · CIK 0001463638 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,000

Underlying: Common Stock · 5,000 shares

Expires 2031-12-14

F1 · shares: On December 14, 2021, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's common stock with an exercise price of $37.13 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 12/14/2022.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 7,000 shares of common stock at a price of $26.88 per share with initial Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) 10,000 shares of common stock at a price of $31.82 with initial Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) 10,000 shares of common stock at a price of $30.44 per share with initial Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026;

F3 · balance_after: (d) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (e) 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (f) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028; (g) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029;

F4 · balance_after: (h) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; and (i) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award.

SEC source: 0001415889-21-006154 · form4-12212021_041205.xml · derivative · entry 4

MITCHELL W G CHAMPION · CIK 0001204823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,750

Underlying: Common Stock · 1,750 shares

Expires 2024-12-14

F4 · shares: On December 14, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/14/2024.

SEC source: 0001415889-21-006154 · form4-12212021_041205.xml · derivative · entry 3

MITCHELL W G CHAMPION · CIK 0001204823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,667

Underlying: Common Stock · 5,000 shares

Expires 2031-12-14

F1 · shares: On December 14, 2021, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $37.13 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/14/2022.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (b) 6,667 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (c) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable on 12/12/2019 and Expiration Date of 12/12/2028; (d) 10,000 shares of common stock at a price of $40.15 per share with an initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; (e) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; and

F3 · balance_after: (i) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award.

SEC source: 0001415889-21-004995 · form4-10272021_021050.xml · nonDerivative · entry 1

Griffin William F Jr · CIK 0001384123 · Director · GEMMA, NON-EXECUTIVE CHAIRMAN

10b5-1 filing: Not disclosed

Ownership: Indirect · By William F Griffin Jr Revocable Trust U/A DTD FBO 12/09/04

Disclosed balance after: 196,150

SEC source: 0001415889-21-004924 · form4-10202021_011036.xml · derivative · entry 3

Griffin William F Jr · CIK 0001384123 · Director · GEMMA, NON-EXECUTIVE CHAIRMAN

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2022-12-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.underlying_shares: On October 18, 2021, the Reporting person exercised his option to purchase 10,000 shares of the Issuer's common stock at price of $18.87 per share.

SEC source: 0001415889-21-004924 · form4-10202021_011036.xml · nonDerivative · entry 2

Griffin William F Jr · CIK 0001384123 · Director · GEMMA, NON-EXECUTIVE CHAIRMAN

10b5-1 filing: Not disclosed

Ownership: Indirect · By William F Griffin Jr Revocable Trust U/A DTD FBO 12/09/04

Disclosed balance after: 206,150

F2 · shares: On October 18, 2021, the Reporting Person sold 10,000 shares of the Issuer's common stock on the open market at a price of $44.25 per share.

SEC source: 0001415889-21-004924 · form4-10202021_011036.xml · nonDerivative · entry 1

Griffin William F Jr · CIK 0001384123 · Director · GEMMA, NON-EXECUTIVE CHAIRMAN

10b5-1 filing: Not disclosed

Ownership: Indirect · By William F Griffin Jr Revocable Trust U/A DTD FBO 12/09/04

Disclosed balance after: 216,150

F1 · shares: On October 18, 2021, the Reporting person exercised his option to purchase 10,000 shares of the Issuer's common stock at price of $18.87 per share.

SEC source: 0001415889-21-004799 · form4-10072021_021025.xml · nonDerivative · entry 2

Griffin William F Jr · CIK 0001384123 · Director · GEMMA, NON-EXECUTIVE CHAIRMAN

10b5-1 filing: Not disclosed

Ownership: Indirect · By William F Griffin Jr Revocable Trust U/A DTD FBO 12/09/04

Disclosed balance after: 206,150

SEC source: 0001415889-21-004799 · form4-10072021_021025.xml · nonDerivative · entry 1

Griffin William F Jr · CIK 0001384123 · Director · GEMMA, NON-EXECUTIVE CHAIRMAN

10b5-1 filing: Not disclosed

Ownership: Indirect · By William F Griffin Jr Revocable Trust U/A DTD FBO 12/09/04

Disclosed balance after: 209,150

SEC source: 0001104659-21-056553 · tm2114480-1_4seq1.xml · derivative · entry 6

Koilpillai Mano S · CIK 0001790160 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,667

Underlying: Common Stock · 702 shares

Expires 2029-12-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $42.31 per share with initial Date Exercisable of 9/10/2020 and Expiration Date of 9/10/2029; (b) 6,667 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; and (c) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030, all of which vest ratably over three years on the anniversary of each grant date.

SEC source: 0001104659-21-056553 · tm2114480-1_4seq1.xml · nonDerivative · entry 4

Koilpillai Mano S · CIK 0001790160 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180

F4 · shares: On April 27, 2021 the Reporting Person sold 522 shares of common stock on the open market at an average price of $49.94 per share.

SEC source: 0001104659-21-056553 · tm2114480-1_4seq1.xml · nonDerivative · entry 3

Koilpillai Mano S · CIK 0001790160 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 702

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: On April 27, 2021, the Reporting Person exercised her stock option received on December 23, 20219 to purchase 702 shares of the Issuer's common stock at a price of $40.15 per share.

SEC source: 0001104659-21-056553 · tm2114480-1_4seq1.xml · derivative · entry 5

Koilpillai Mano S · CIK 0001790160 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,369

Underlying: Common Stock · 2,631 shares

Expires 2029-12-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $42.31 per share with initial Date Exercisable of 9/10/2020 and Expiration Date of 9/10/2029; (b) 6,667 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; and (c) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030, all of which vest ratably over three years on the anniversary of each grant date.

SEC source: 0001104659-21-056553 · tm2114480-1_4seq1.xml · nonDerivative · entry 2

Koilpillai Mano S · CIK 0001790160 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · shares: On April 26, 2021, the Reporting Person sold 2,631 shares of common stock on the open market at an average price of $50.16 per share.